Literature DB >> 12731676

In vivo platelet activation and hyperaggregation in hemoglobin E/beta-thalassemia: a consequence of splenectomy.

Vichai Atichartakarn1, Pantep Angchaisuksiri, Katcharin Aryurachai, Suporn Chuncharunee, Ammarin Thakkinstian.   

Abstract

Patients with hemoglobin E/beta-thalassemia (E/beta-Thal) who have undergone splenectomy are prone to thrombosis in the small pulmonary arteries. To study the role of platelets in this situation, we assayed plasma beta2-thromboglobulin (betaTG) and performed whole blood platelet aggregation analysis of 30 E/beta-Thal patients, half of whom had undergone splenectomy. We compared results with those obtained with 15 healthy control subjects. Plasma betaTG levels in splenectomy patients were significantly higher than in control subjects and patients who had not undergone splenectomy, and platelets in splenectomy patients exhibited hyperaggregation in response to adenosine diphosphate, thrombin, and ristocetin. Levels of plasma thrombin-antithrombin III complex were also significantly higher. This finding is likely due to an increased number of erythrocytes with exposed phosphatidylserines, an effect that has been associated with splenectomy. The increased presence of thrombin in the blood may well be the cause of platelet hyperactivity, which was evident only in the asplenic patients Platelet hyperactivity very likely plays a pathogenetic role in the thrombosis of small pulmonary arteries that occurs in E/beta-Thal patients who have undergone splenectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731676     DOI: 10.1007/bf02983790

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  30 in total

1.  Pathogenesis of hypoxemia.

Authors:  U Chantharaksri; W Tonsuwonnont; S Fucharoen; P Wasi
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992       Impact factor: 0.267

2.  Morphological assessment of platelet activation in thalassemia.

Authors:  A Bunyaratvej; N Komanasin; S Sriurairatana; S Fucharoen
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992       Impact factor: 0.267

3.  Oxygen free radical-dependent increased platelet function in beta-thalassemia major patients.

Authors:  M Pasin; S Yavuzer; M Tekin; N Akar; F Violi
Journal:  Thromb Res       Date:  1998-12-15       Impact factor: 3.944

4.  Thromboembolic events in beta thalassemia major: an Italian multicenter study.

Authors:  C Borgna Pignatti; V Carnelli; V Caruso; F Dore; D De Mattia; A Di Palma; F Di Gregorio; M A Romeo; R Longhi; A Mangiagli; C Melevendi; G Pizzarelli; S Musumeci
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

5.  Cytokine induction of platelet activation.

Authors:  J A Lumadue; S M Lanzkron; S D Kennedy; D T Kuhl; T S Kickler
Journal:  Am J Clin Pathol       Date:  1996-12       Impact factor: 2.493

Review 6.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

Authors:  R F Zwaal; A J Schroit
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

7.  Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.

Authors:  D Helley; A Eldor; R Girot; R Ducrocq; M C Guillin; A Bezeaud
Journal:  Thromb Haemost       Date:  1996-09       Impact factor: 5.249

8.  Increased circulating platelet aggregates in thalassaemia.

Authors:  P Winichagoon; S Fucharoen; P Wasi
Journal:  Southeast Asian J Trop Med Public Health       Date:  1981-12       Impact factor: 0.267

9.  In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites.

Authors:  A Eldor; F Lellouche; A Goldfarb; E A Rachmilewitz; J Maclouf
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

10.  Acquired dysfunction due to the circulation of "exhausted" platelets.

Authors:  F I Pareti; A Capitanio; L Mannucci; C Ponticelli; P M Mannucci
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  17 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.

Authors:  Emanuela Ferru; Antonella Pantaleo; Franco Carta; Franca Mannu; Amina Khadjavi; Valentina Gallo; Luisa Ronzoni; Giovanna Graziadei; Maria Domenica Cappellini; Francesco Turrini
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

3.  Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.

Authors:  Roberto F Machado; Mark T Gladwin
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

Review 4.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

5.  Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.

Authors:  Alice Trinchero; Marina Marchetti; Cinzia Giaccherini; Carmen J Tartari; Laura Russo; Anna Falanga
Journal:  Blood Transfus       Date:  2016-10-04       Impact factor: 3.443

6.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

7.  Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.

Authors:  Sylvia T Singer; Frans Kuypers; Jeffery Fineman; Ginny Gildengorin; Sandra Larkin; Nancy Sweeters; Howard Rosenfeld; Gregory Kurio; Annie Higa; Michael Jeng; James Huang; Elliott P Vichinsky
Journal:  Ann Hematol       Date:  2014-02-28       Impact factor: 3.673

Review 8.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 9.  Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.

Authors:  Roberto F Machado; Harrison W Farber
Journal:  Clin Chest Med       Date:  2013-10-17       Impact factor: 2.878

10.  Coagulopathy in Beta-thalassemia: current understanding and future perspectives.

Authors:  M Domenica Cappellini; Khaled M Musallam; Alessia Marcon; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.